Pēd. atjaunots: 01.07.2024 20:11 (GMT+3)

Farmaatsiatehas: Resolutions of the annual general meeting of shareholders

30.04.1999, Tallinna Farmaatsiatehas, TLN
TALLINNA FARMAATSIATEHASE  AS  
ANNOUNCEMENT
30.04.99

RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS

21 shareholders/representatives participated in the 30.04.1999 AGM of
Tallinna Farmaatsiatehase AS, representing 80.3% of total votes
represented with shares.

The annual general meeting of Tallinna Farmaatsiatehase AS shareholders
resolved:

1.Approve the 1998 annual report of Tallinna Farmaatsiatehase AS along
with the auditor report.

2.Approve the loss of Tallinna Farmaatsiatehase AS in the financial
year of 1998 in total amount of 92 825 930 EEK. Due to the fact that
the company earned no profit in 1998, there will be no profit
distribution between shareholders.

3. Recall the members of the Supervisory Board of TFT AS Margus
Linnamäe, Ülar Maapalu, Inga Kuusik, Valdis Jakobsons and Andres Toome.

4. To elect Vitaljis Skrivelis (36), Elita Liela (39) ja Sander Zibo
(25) new members of the Supervisory Board; not to elect Marcel Vichmann
a new member of the Supervisory Board.

5. Appoint Urmas Kaarlep of AS PriceWaterhouseCoopers to audit the
financial statements of TFT AS in the financial year of 1999.

6. Approve the new Articles of Association of Tallinna Farmaatsiatehase
AS in redaction presented by the Management Board.

7. Reduction of share capital volume of TFT AS in simplified form,
through partial cancellation of shares from EEK 37 700 340 to the level
of EEK 12 500 000, in the course of which 2 520 034 nominal ordinary
shares will be cancelled.
The list of shareholders will be fixed as of 17.05.1999.

The company’s share capital will be reduced due to decrease in the
company’s net assets to the level of less than half of the volume of
share capital, proceeding from what the general meeting must resolve
on the issue of reduction of share capital (pursuant to § 301 of the
Commercial Law). In the course of the share capital reduction, the
shares held by all shareholders will be cancelled proportionally with
the number of shares owned.
In order to find the number of shares to be cancelled, to round the
number of shares to be cancelled upwards. Based on the written
applications the shareholders present to the Management Board, to
compensate the differences proceeding from rounding of shares in three
months after registration of the reduction in share capital in the
Commercial Register on the basis of market price of the share on
17.05.99.

To authorize the Management Board of the company to register the
reduction of share capital of Tallinna Farmaatsiatehase AS in the
Commercial Register, and make the respective entries (regarding
cancellation of shares) to the list of shareholders.

8. Increase of share capital via the issuance of new shares for
additional monetary payments from EEK 12 500 000 to EEK 18 500 000,
in the course of which the company will issue additionally 600 000
nominal shares at par value of EEK 10 per share.

The share capital will be increased to stabilize the company’s
financial standings and inclusion of additional investments.

Pursuant to § 345, section 1, of the Commercial Law, the shareholders
can exercise pre-emptive right to subscribe for the new shares to be
issued proportionally with the sum of the nominal values of previously
owned shares. The deadline for pre-emptive subscription right is
31.05.1999. The shares can be subscribed for in the city of Tallinn.
The payment for shares subscribed must be made before June 10, 1999.

To determine the circle of shareholders with pre-emptive subscription
right, the shareholders’ list will be fixed as of 17.05.1999.

Upon oversubscription, the provisions of § 346 of the Commercial Law
will be applied. Upon undersubscription, the provisions of § 347 of
the Commercial Law will be applied. Upon undersubscription, the
Management Board is entitled to cancel the shares not subscribed for,
or extend the subscription period by additional three weeks.

The shares to be issued entitle the shareholders for dividends in
2003 for the financial year 2002.


Arno Kaseniit
Member of the Management Board
Tel. +372 61 20 201

Vērtspapīri

Akcijas
Obligācijas
Ieguldījumu Fondi

Tirgus informācija

Statistika
Tirdzniecība
Indeksi
Izsoles

Noteikumi

Biržas noteikumi
Uzraudzība

Nāc uz Biržu

Uzņēmumiem
Investoriem
Biržas biedriem
First North konsultantiem

Aktualitātes

Nasdaq ziņas
Emitentu ziņas
Kalendārs

Par mums

Nasdaq Baltijas tirgus
Biroji